Linear nevus sebaceous syndrome is a rare congenital disorder characterized by the presence of linear skin lesions consisting of hyperplastic sebaceous glands. The disease usually manifests itself at birth or in early childhood and is localized predominantly on the face, neck, and scalp. The pathogenesis of the disease is associated with mosaic postzygotic mutations in the KRAS or HRAS oncogene, which leads to abnormal development of epithelial tissue. The clinical picture can vary from isolated cutaneous manifestations to a combined form involving the central nervous system.
History of the disease and interesting historical facts
The first detailed description of linear nevus sebaceous syndrome was presented by Jadassohn in 1903, but the most complete clinical picture was described by the Soviet dermatologist M.S. Shapiro in 1957. It is interesting to note that the disease was initially considered exclusively dermatological, but systemic manifestations were later identified. “This unique condition demonstrates a classic example of mosaicism in action,” noted the famous geneticist Robert Gorlin in his 1983 work. According to historical data, the prevalence of the disease varied significantly depending on the geographic region.
Epidemiology (statistics of disease occurrence)
The disease occurs with a frequency of 1-3 cases per 1000 newborns. According to an international study conducted in 2018, the ratio of male to female lesions is 1:1.2. The Caucasian and Mongoloid races are most often affected, while the disease is diagnosed less frequently in representatives of the Negroid race. The table below presents data on the prevalence of the disease by region:
- Europe - 2.5 cases per 1000 newborns
- USA - 2.8 cases per 1000 live births
- Asia - 1.8 cases per 1000 newborns
- Africa - 0.9 cases per 1000 live births
Genetic predisposition to the disease (involved genes and mutations)
The main pathogenetic mechanism of disease development is postzygotic mutations in the genes of the RAS-MAPK signaling pathway. Studies have shown the following features of the mutation profile:
- Mutations in the KRAS gene - 60% cases
- Mutations in the HRAS gene - 30% cases
- Mutations in other components of the signaling pathway are less common.
“Mutations occur early in embryogenesis, which explains the mosaic nature of the lesion,” the researchers concluded in a paper published in the journal Nature Genetics (2015).
Risk factors for the development of this disease
The main risk factors include:
- Exposure to ionizing radiation during pregnancy
- Taking certain medications (cytostatics, anticonvulsants)
- Unfavorable environmental living conditions
- The predominantly urban lifestyle of a pregnant woman
The first trimester of pregnancy is especially important, when the main organs and systems of the fetus are formed.
Diagnosis of this disease
The main diagnostic criteria include:
- Clinical manifestations: linear yellowish plaques, hyperkeratosis, focal alopecia
- Laboratory tests: histological examination of skin biopsy
- Radiological methods: MRI of the brain if cerebral manifestations are suspected
- Molecular genetic tests: analysis of mutations in KRAS/HRAS genes
Differential diagnosis is carried out with other types of cutaneous nevi, especially with basal cell nevus.
Treatment
The therapeutic approach includes a comprehensive impact:
- Drug treatment: anti-inflammatory drugs, retinoids
- Surgical treatment: excision of the formation, laser therapy
- Physiotherapeutic methods: cryotherapy, electrocoagulation
- Systemic therapy: in the presence of neurological complications
List of drugs used to treat this disease
- Acitretin (up to 0.5 mg/kg body weight)
- Isotretinoin (0.1-0.2 mg/kg body weight)
- Topical corticosteroids (class II-III)
- 5-fluorouracil topically
- Imiquimod 5% cream
Disease monitoring
Regular monitoring includes:
- Follow-up examinations every 6 months
- Dermoscopy of the affected areas
- Assessment of neurological status
- Ultrasound of regional lymph nodes
The prognosis with timely treatment is favorable, but the risk of malignancy is 5-10%.
Age-related features of the disease
At different age periods the disease has its own characteristics:
- Newborns: reddish spots with minimal infiltration predominate
- Childhood: increased papillomatosis and hyperkeratosis
- Adolescence: activation of sebaceous gland function
- Adult population: high risk of transformation into basal cell carcinoma
Questions and Answers
- How often should I get checked? An annual examination is recommended, including dermatoscopy and consultation with a neurologist.
- Is it possible to completely cure the disease? Complete cure is possible only by surgery, but there is a risk of relapse.
- What is the likelihood of the disease being passed on to children? The probability is extremely low, since the mutation is postzygotic.
- What are the restrictions in everyday life? It is necessary to avoid trauma to the affected areas and prolonged sun exposure.
- Is it possible for elements to disappear spontaneously? In young children, partial regression is possible, but requires constant monitoring.
Advice from Dr. Oleg Korzhikov
As an experienced dermatologist, I often hear the following questions from patients:
- How to distinguish a common birthmark from a sebaceous nevus? Pay attention to the surface texture - nevus sebaceous glands have a characteristic yellowish color and roughness
- What to do if changes appear in a nevus? Consult a dermatologist immediately for a dermatoscopy.
- How to protect affected areas? Use sunscreen SPF 50+, avoid mechanical damage
Remember that regular monitoring and timely treatment will help avoid serious complications.
